The coronavirus illness 2019 (COVID-19) pandemic, brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is threatening folks’s lives and impacting their well being. It’s nonetheless unclear whether or not folks engaged in bodily exercise are at an elevated danger of SARS-CoV-2 an infection and extreme types of COVID-19.
To be able to present knowledge to assist reply this query, we, subsequently, investigated the results of endurance coaching on the degrees of host proteins concerned in SARS-CoV-2 an infection in mice. Eight-week-old C57BL/6J mice have been subjected to treadmill operating (17-25 m/min, 60-90 min, 5 classes/week, eight weeks).
After the intervention, the degrees of angiotensin-converting enzyme 2 (ACE2; host receptor for SARS-CoV-2), transmembrane protease serine 2 (TMPRSS2; host protease priming fusion of SARS-CoV-2 to host cell membranes), FURIN (host protease that promotes binding of SARS-CoV-2 to host receptors), and Neuropilin-1 (host coreceptor for SARS-CoV-2) have been measured in 10 organs that SARS-CoV-2 can infect (larynx, trachea, lung, coronary heart, jejunum, ileum, colon, liver, kidney, and testis).
Six organs (coronary heart, lung, jejunum, liver, trachea, and ileum) confirmed modifications within the ranges of at the very least one of many proteins. Endurance coaching elevated ACE2 ranges in coronary heart (+66.4%), lung (+37.1%), jejunum (+24.7%) and liver (+27.4%), and FURIN in liver (+17.9%) tissue. In distinction, endurance coaching decreased Neuropilin-1 ranges in liver (-39.7%), trachea (-41.2%), and ileum (-39.7%), and TMPRSS2 in lung (-11.3%). Taken collectively, endurance coaching altered the degrees of host proteins concerned in SARS-CoV-2 cell entry in an organ-dependent method.
A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 An infection and Its Software in a Inhabitants-Based mostly Survey by Mail
Noninvasive salivary antibody immunoassays can allow low-cost epidemiological surveillance of infections. This research concerned creating and validating a multiplex suspension immunoassay on the Luminex platform to measure immunoglobulin G (IgG) responses to extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid and spike (S) proteins, and the spike protein’s S1 and S2 subunits and receptor binding area.
A number of variations of those recombinant proteins acquired from industrial and noncommercial sources have been evaluated. Assay growth and validation utilized saliva and serum samples from coronavirus illness 2019 (COVID-19) instances procured from industrial sources and damaging controls from a prepandemic survey.
Saliva was additionally collected in an illustration survey by mail involving grownup people in the US who have been recognized with SARS-CoV-2 an infection 15 to 80 days previous to pattern assortment. The survey had an 83% legitimate pattern return price (192 samples from 38 states).
Most COVID-19 instances (93%) reported mildly symptomatic or asymptomatic infections. The ultimate salivary assay primarily based on the best-performing spike and nucleocapsid proteins had a sensitivity of 87.1% (95% bootstrap confidence interval, 82.1 to 91.7%) and specificity of 98.5% (95.Zero to 100%) utilizing 227 and 285 saliva samples, respectively.
The identical assay had 95.9% (92.eight to 98.9%) sensitivity and 100% (98.Four to 100%) specificity in serum (174 and 285 serum samples, respectively). Salivary and serum antibody responses to spike and nucleocapsid proteins have been strongly correlated in 22 paired samples (r = 0.88 and r = 0.80, respectively). Antibody responses peaked at roughly 50 days postonset; higher sickness severity was related to stronger responses.
This research demonstrated {that a} salivary antibody assay can be utilized in large-scale inhabitants surveys by mail to raised characterize public well being impacts of COVID-19. IMPORTANCE Given the big impacts of the COVID-19 pandemic, creating instruments for inhabitants surveillance of an infection is of paramount significance.
This text describes the event of a multiplex immunoassay on a Luminex platform to measure salivary immunoglobulin G responses to the spike protein, its two subunits and receptor binding area, and the nucleocapsid protein of SARS-CoV-2. The assay validation utilized serum and saliva samples from prepandemic controls and up to date COVID-19 instances.
A survey by mail focusing on current COVID-19 instances throughout the US additionally demonstrated the utility of secure, at-home self-collection of saliva. By incorporating a number of SARS-CoV-2 proteins, this assay might differentiate responses to pure SARS-CoV-2 infections from responses to most vaccines.
Software of this noninvasive immunoassay in COVID-19 surveillance will help present estimates of cumulative incidence charges of symptomatic and asymptomatic infections in varied communities and subpopulations, temporal patterns of antibody responses, and danger components for an infection.
Roborovski hamster (Phodopus roborovskii) pressure SH101 as a systemic an infection mannequin of SARS-CoV-2
Extreme acute respiratory syndrome CoV-2 (SARS-CoV-2) is presently inflicting a worldwide menace with its unusually excessive transmission charges and fast evolution into various strains. In contrast to typical respiratory viruses, SARS-CoV-2 ceaselessly causes systemic an infection by breaking the boundaries of the respiratory methods.
The event of animal fashions recapitulating the medical manifestations of COVID-19 is of utmost significance not just for the event of vaccines and antivirals but additionally for understanding the pathogenesis. Nonetheless, there has not been developed an animal mannequin for systemic an infection of SARS-CoV-2 representing most features of the medical manifestations of COVID-19 with systemic signs.
Right here we report {that a} Roborovski hamster pressure SH101, a laboratory inbred hamster pressure of P. roborovskii, displayed most signs of systemic an infection upon SARS-CoV-2 an infection as within the case of the human counterpart, in contrast to present COVID-19 animal fashions.
Roborovski hamster pressure SH101 post-infection of SARS-CoV-2 represented most medical signs of COVID-19 resembling snuffling, labored respiratory, dyspnea, cough, hunched posture, progressive weight reduction, ruffled fur, and excessive fever following shaking chills.
Histological examinations additionally revealed preliminary right-predominated pneumonia in addition to slight organ damages within the mind and liver, manifesting systemic COVID-19 instances. Contemplating the advantage of a small animal in addition to its medical manifestations of SARS-CoV-2 an infection in human, this hamster mannequin appears to supply a perfect software to research COVID-19.
A mathematical mannequin for the dynamics of SARS-CoV-2 virus utilizing the Caputo-Fabrizio operator
The pandemic of SARS-CoV-2 virus stays a urgent problem with unpredictable traits which unfold worldwide via human interactions. The present research is specializing in the investigation and evaluation of a fractional-order epidemic mannequin that discusses the temporal dynamics of the SARS-CoV-2 virus in a group. It’s well-known that symptomatic and asymptomatic people have a significant impact on the dynamics of the SARS-CoV-2 virus subsequently, we divide the whole inhabitants into inclined, asymptomatic, symptomatic, and recovered teams of the inhabitants.
Additional, we assume that the vaccine confers everlasting immunity as a result of a number of vaccinations have commenced throughout the globe. The brand new fractional-order mannequin for the transmission dynamics of SARS-CoV-2 virus is formulated by way of the Caputo-Fabrizio fractional-order method with the upkeep of dimension in the course of the technique of fractionalization.
The speculation of mounted level will probably be used to point out that the proposed mannequin possesses a novel answer whereas the well-posedness (bounded-ness and positivity) of the fractional-order mannequin options are mentioned.
Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-1mg |
QP13422-1mg |
EnQuireBio |
1mg |
EUR 1061 |
Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-500ug |
QP13422-500ug |
EnQuireBio |
500ug |
EUR 663 |
Recombinant SARS Associated Spike Mosaic S(N) |
7-07093 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(N) |
7-07094 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(N) |
7-07095 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(M) |
7-07096 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(M) |
7-07097 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S(M) |
7-07098 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S© |
7-07099 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S© |
7-07100 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Spike Mosaic S© |
7-07101 |
CHI Scientific |
1000µg |
Ask for price |
SARS Associated Spike Mosaic S(M) Protein |
20-abx260155 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1372.00
|
|
|
SARS Associated Spike Mosaic S(N) Protein |
20-abx260157 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1372.00
|
|
|
Recombinant (E.Coli) SARS Associated Spike Mosaic S |
RP-1422 |
Alpha Diagnostics |
100 ug |
EUR 286 |
Recombinant (E.Coli) SARS Associated Spike Mosaic S |
RP-1423 |
Alpha Diagnostics |
100 ug |
EUR 286 |
Recombinant (E.Coli) SARS Associated Spike Mosaic S |
RP-1424 |
Alpha Diagnostics |
100 ug |
EUR 286 |
Recombinant SARS Spike Mosaic Protein S (N-Terminal) |
VAng-Lsx0073-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli. |
Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573) |
VAng-Lsx0056-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203) |
VAng-Lsx0055-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190) |
VAng-Lsx0057-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
SARS antibody |
70R-20086 |
Fitzgerald |
50 ul |
EUR 435 |
Description: Rabbit polyclonal SARS antibody |
SARS antibody |
70R-1444 |
Fitzgerald |
100 ug |
EUR 377 |
Description: Rabbit polyclonal SARS antibody raised against the C terminal of SARS |
SARS antibody |
70R-1445 |
Fitzgerald |
100 ug |
EUR 377 |
Description: Rabbit polyclonal SARS antibody raised against the middle region of SARS |
SARS Antibody |
1-CSB-PA04145A0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
SARS Antibody |
1-CSB-PA020709GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against SARS. Recognizes SARS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
SARS siRNA |
20-abx932473 |
Abbexa |
|
|
|
SARS siRNA |
20-abx932474 |
Abbexa |
|
|
|
SARS siRNA |
20-abx904776 |
Abbexa |
|
|
|
SARS antibody |
39139-100ul |
SAB |
100ul |
EUR 252 |
Cytomegalo Virus Mosaic |
PR27123 |
Neuromics |
500 ug |
EUR 833 |
Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug |
QP13416-100ug |
EnQuireBio |
100ug |
EUR 218 |
Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg |
QP13416-1mg |
EnQuireBio |
1mg |
EUR 1061 |
Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug |
QP13416-500ug |
EnQuireBio |
500ug |
EUR 663 |
Recombinant SARS SARS Envelope Protein, Untagged, E.coli-100ug |
QP13417-100ug |
EnQuireBio |
100ug |
EUR 218 |
Recombinant SARS SARS Envelope Protein, Untagged, E.coli-1mg |
QP13417-1mg |
EnQuireBio |
1mg |
EUR 1061 |
Recombinant SARS SARS Envelope Protein, Untagged, E.coli-500ug |
QP13417-500ug |
EnQuireBio |
500ug |
EUR 663 |
Recombinant SARS SARS Matrix Protein, Untagged, E.coli-100ug |
QP13418-100ug |
EnQuireBio |
100ug |
EUR 218 |
Recombinant SARS SARS Matrix Protein, Untagged, E.coli-1mg |
QP13418-1mg |
EnQuireBio |
1mg |
EUR 1061 |
Recombinant SARS SARS Matrix Protein, Untagged, E.coli-500ug |
QP13418-500ug |
EnQuireBio |
500ug |
EUR 663 |
Recombinant SARS SARS MERS Protein, His, E.coli-100ug |
QP13419-100ug |
EnQuireBio |
100ug |
EUR 218 |
Recombinant SARS SARS MERS Protein, His, E.coli-1mg |
QP13419-1mg |
EnQuireBio |
1mg |
EUR 1261 |
Recombinant SARS SARS MERS Protein, His, E.coli-500ug |
QP13419-500ug |
EnQuireBio |
500ug |
EUR 663 |
Recombinant SARS SARS-CoV Protein, His, E.coli-1mg |
QP13423-1mg |
EnQuireBio |
1mg |
EUR 3954 |
Recombinant SARS SARS-CoV Protein, His, E.coli-20ug |
QP13423-20ug |
EnQuireBio |
20ug |
EUR 201 |
Recombinant SARS SARS-CoV Protein, His, E.coli-5ug |
QP13423-5ug |
EnQuireBio |
5ug |
EUR 155 |
Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug |
QP10499-100ug |
EnQuireBio |
100ug |
EUR 218 |
Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg |
QP10499-1mg |
EnQuireBio |
1mg |
EUR 1061 |
Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug |
QP10499-500ug |
EnQuireBio |
500ug |
EUR 663 |
Anti-SARS (1H4) |
YF-MA10816 |
Abfrontier |
100 ug |
EUR 363 |
Description: Mouse monoclonal to SARS |
SARS Blocking Peptide |
33R-8713 |
Fitzgerald |
100 ug |
EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1445 |
SARS Blocking Peptide |
33R-7048 |
Fitzgerald |
100 ug |
EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1444 |
SARS E2 antibody |
10R-1976 |
Fitzgerald |
100 ul |
EUR 241 |
Description: Mouse monoclonal SARS E2 antibody |
SARS M antibody |
10R-1977 |
Fitzgerald |
100 ul |
EUR 241 |
Description: Mouse monoclonal SARS M antibody |
SARS Coronavirus antibody |
10C-CR9003M1 |
Fitzgerald |
100 ug |
EUR 499 |
Description: Mouse monoclonal SARS Coronavirus antibody |
SARS Nucleocapsid antibody |
10R-10470 |
Fitzgerald |
100 ug |
EUR 435 |
Description: Mouse monoclonal SARS Nucleocapsid antibody |
SARS Nucleocapsid antibody |
10R-10471 |
Fitzgerald |
100 ug |
EUR 435 |
Description: Mouse monoclonal SARS Nucleocapsid antibody |
SARS cloning plasmid |
CSB-CL020709HU1-10ug |
Cusabio |
10ug |
EUR 376 |
|
Description: A cloning plasmid for the SARS gene. |
SARS cloning plasmid |
CSB-CL020709HU2-10ug |
Cusabio |
10ug |
EUR 376 |
|
Description: A cloning plasmid for the SARS gene. |
SARS Spike Antibody |
20-abx137184 |
Abbexa |
-
EUR 1052.00
-
EUR 1539.00
-
EUR 1720.00
|
|
|
SARS Nucleocapsid Antibody |
20-abx137185 |
Abbexa |
-
EUR 1052.00
-
EUR 1539.00
-
EUR 1970.00
|
|
|
SARS Spike Antibody |
20-abx137200 |
Abbexa |
-
EUR 1177.00
-
EUR 1887.00
-
EUR 2221.00
|
|
|
SARS Nucleocapsid Antibody |
20-abx137201 |
Abbexa |
-
EUR 1177.00
-
EUR 1887.00
-
EUR 2221.00
|
|
|
SARS-E2 Antibody |
abx016055-100ul |
Abbexa |
100 ul |
EUR 411 |
|
SARS-M Antibody |
abx016056-100ul |
Abbexa |
100 ul |
EUR 411 |
|
SARS Polyclonal Antibody |
A53977 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: The best epigenetics products |
SARS Rabbit pAb |
A6733-100ul |
Abclonal |
100 ul |
EUR 308 |
SARS Rabbit pAb |
A6733-200ul |
Abclonal |
200 ul |
EUR 459 |
SARS Rabbit pAb |
A6733-20ul |
Abclonal |
20 ul |
EUR 183 |
SARS Rabbit pAb |
A6733-50ul |
Abclonal |
50 ul |
EUR 223 |
SARS Rabbit pAb |
A13350-100ul |
Abclonal |
100 ul |
EUR 308 |
SARS Rabbit pAb |
A13350-200ul |
Abclonal |
200 ul |
EUR 459 |
SARS Rabbit pAb |
A13350-20ul |
Abclonal |
20 ul |
EUR 183 |
SARS Rabbit pAb |
A13350-50ul |
Abclonal |
50 ul |
EUR 223 |
Anti-SARS antibody |
STJ28816 |
St John's Laboratory |
100 µl |
EUR 277 |
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown. |
SARS Spike Antibody |
24216-100ul |
SAB |
100ul |
EUR 390 |
SARS Spike Antibody |
24217-100ul |
SAB |
100ul |
EUR 390 |
SARS Spike Antibody |
24218-100ul |
SAB |
100ul |
EUR 390 |
SARS Spike Antibody |
24219-100ul |
SAB |
100ul |
EUR 390 |
SARS Spike Antibody |
24318-100ul |
SAB |
100ul |
EUR 390 |
SARS Matrix Antibody |
24319-100ul |
SAB |
100ul |
EUR 390 |
SARS Matrix Antibody |
24320-100ul |
SAB |
100ul |
EUR 390 |
SARS Envelope Antibody |
24321-100ul |
SAB |
100ul |
EUR 390 |
SARS Envelope Antibody |
24322-100ul |
SAB |
100ul |
EUR 390 |
Anti-SARS antibody |
STJ115313 |
St John's Laboratory |
100 µl |
EUR 277 |
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown. |
SARS Conjugated Antibody |
C39139 |
SAB |
100ul |
EUR 397 |
SARS Protease Substrate |
H-5982.0500 |
Bachem |
0.5mg |
EUR 297 |
Description: Sum Formula: C66H119N21O22S; CAS# [587886-51-9] net |
SARS Protease Substrate |
H-5982.1000 |
Bachem |
1.0mg |
EUR 515 |
Description: Sum Formula: C66H119N21O22S; CAS# [587886-51-9] net |
anti- SARS antibody |
FNab07609 |
FN Test |
100µg |
EUR 548.75 |
|
Description: Antibody raised against SARS |
Turnip mosaic virus Polyprotein |
1-CSB-EP2708TJM |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Turnip mosaic virus Polyprotein,partial expressed in E.coli |
Recombinant Malaria Cs Mosaic |
7-07090 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Malaria Cs Mosaic |
7-07091 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Malaria Cs Mosaic |
7-07092 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant Cytomegalo Virus Mosaic |
7-07525 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Cytomegalo Virus Mosaic |
7-07526 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Cytomegalo Virus Mosaic |
7-07527 |
CHI Scientific |
1000µg |
Ask for price |
HTLV-1 Mosaic Protein |
20-abx260286 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1609.00
|
|
|
Malaria Cs Mosaic Protein |
20-abx260295 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1609.00
|
|
|
Recombinant HEV Mosaic Protein |
VAng-Lsx0225-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HEV Mosaic Protein, recombinant protein from E. coli. |
Rubella Virus E1 Mosaic |
PR27125 |
Neuromics |
500 ug |
EUR 833 |
SARS protein (His tag) |
80R-2099 |
Fitzgerald |
50 ug |
EUR 322 |
Description: Recombinant human SARS protein (His tag) |
SARS Antibody, HRP conjugated |
1-CSB-PA04145B0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
SARS Antibody, FITC conjugated |
1-CSB-PA04145C0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
SARS Antibody, Biotin conjugated |
1-CSB-PA04145D0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
anti-SARS-E2 (4A6C9) |
LF-MA30016 |
Abfrontier |
100 ul |
EUR 344 |
Description: Mouse Monoclonal to SARS-E2 |
anti-SARS-M (2H2C4) |
LF-MA30017 |
Abfrontier |
100 ul |
EUR 354 |
Description: Mouse Monoclonal to SARS-M |
SARS Recombinant Protein (Human) |
RP027604 |
ABM |
100 ug |
Ask for price |
SARS Recombinant Protein (Human) |
RP027607 |
ABM |
100 ug |
Ask for price |
SARS Recombinant Protein (Rat) |
RP227480 |
ABM |
100 ug |
Ask for price |
SARS Recombinant Protein (Mouse) |
RP170009 |
ABM |
100 ug |
Ask for price |
SARS Recombinant Protein (Mouse) |
RP170012 |
ABM |
100 ug |
Ask for price |
Rat SARS shRNA Plasmid |
20-abx988123 |
Abbexa |
|
|
|
SARS CoV E Protein |
abx060650-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
SARS CoV Nucleocapsid Protein |
abx060652-1mg |
Abbexa |
1 mg |
EUR 1873 |
|
SARS-CoV Nucleocapsid Protein |
abx060653-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
SARS-CoV Nucleocapsid Protein |
abx060654-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
SARS-CoV Spike Protein |
abx060655-1mg |
Abbexa |
1 mg |
EUR 1692 |
|
SARS virus Sn Antibody |
abx032683-400ul |
Abbexa |
400 ul |
EUR 523 |
|
SARS virus Sn Antibody |
abx032683-80l |
Abbexa |
80 µl |
EUR 286 |
|
SARS virus Sm Antibody |
abx032684-400ul |
Abbexa |
400 ul |
EUR 523 |
|
SARS virus Sm Antibody |
abx032684-80l |
Abbexa |
80 µl |
EUR 286 |
|
ACE2 (SARS Receptor) Antibody |
abx032686-400ul |
Abbexa |
400 ul |
EUR 523 |
|
ACE2 (SARS Receptor) Antibody |
abx032686-80l |
Abbexa |
80 µl |
EUR 286 |
|
SARS N Protein Antibody |
abx018255-100ug |
Abbexa |
100 ug |
EUR 384 |
|
SARS N Protein Antibody |
abx018256-100ug |
Abbexa |
100 ug |
EUR 384 |
|
Human SARS shRNA Plasmid |
20-abx954245 |
Abbexa |
|
|
|
Mouse SARS shRNA Plasmid |
20-abx972567 |
Abbexa |
|
|
|
Polyclonal SARS Matrix Antibody |
APR11178G |
Leading Biology |
0.1 mg |
EUR 659 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SARS Matrix . This antibody is tested and proven to work in the following applications: |
Anti-SARS-E2 antibody |
STJ98377 |
St John's Laboratory |
100 µl |
EUR 234 |
Description: Mouse monoclonal to SARS-E2. |
Anti-SARS-M antibody |
STJ98378 |
St John's Laboratory |
100 µl |
EUR 234 |
Description: Mouse monoclonal to SARS-M. |
Recombinant SARS Matrix Protein |
VAng-Lsx0059-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS Matrix, recombinant protein from E. coli. |
Polyclonal SARS Matrix Antibody |
APG02976G |
Leading Biology |
0.1 mg |
EUR 659 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SARS Matrix . This antibody is tested and proven to work in the following applications: |
Cucumber mosaic virus Helicase (ORF1a) |
1-CSB-CF2240CMV |
Cusabio |
-
EUR 965.00
-
EUR 665.00
-
EUR 715.00
|
|
|
Description: Recombinant Cucumber mosaic virus Helicase(ORF1a) expressed in in vitro E.coli expression system |
Recombinant Treponema pallidum p41 Mosaic |
7-07570 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Treponema pallidum p41 Mosaic |
7-07571 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Treponema pallidum p41 Mosaic |
7-07572 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant Rubella Virus E1 Mosaic |
7-07858 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Rubella Virus E1 Mosaic |
7-07859 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Rubella Virus E1 Mosaic |
7-07860 |
CHI Scientific |
1000µg |
Ask for price |
Rubella Virus E1 Mosaic Protein |
abx060646-1mg |
Abbexa |
1 mg |
EUR 1845 |
|
Rubella Virus E1 Mosaic Protein |
abx060647-1mg |
Abbexa |
1 mg |
EUR 1497 |
|
Treponema pallidum p41 Mosaic Protein |
20-abx260173 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1372.00
|
|
|
Rubella Virus E1 Mosaic Protein |
20-abx260310 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1609.00
|
|
|
Cucumber Mosaic Virus ELISA Kit |
abx157282-96tests |
Abbexa |
96 tests |
EUR 668 |
|
HCV NS4 mosaic recombinant antigen |
00155-V-01mg |
Virogen |
0,1 mg |
EUR 267.5 |
|
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
HCV NS4 mosaic recombinant antigen |
00155-V-1000ug |
Virogen |
1000 ug |
EUR 1282.5 |
|
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
Recombinant RuV E1 Mosaic Protein |
VAng-Lsx0488-100g |
Creative Biolabs |
100 µg |
EUR 963 |
Description: RuV E1 Mosaic, recombinant protein from E. coli. |
Recombinant RuV E1 Mosaic Protein |
VAng-Lsx0488-1mg |
Creative Biolabs |
1 mg |
EUR 2156 |
Description: RuV E1 Mosaic, recombinant protein from E. coli. |
Recombinant RuV E1 Mosaic Protein |
VAng-Lsx0488-500g |
Creative Biolabs |
500 µg |
EUR 1577 |
Description: RuV E1 Mosaic, recombinant protein from E. coli. |
Recombinant HEV Mosaic-S Protein |
VAng-Lsx0226-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HEV Mosaic-S Protein, recombinant protein from E. coli. |
Recombinant HTLV Mosaic Protein [GST] |
VAng-Lsx0304-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant HTLV protein fused with GST at N-terminus was expressed in E. coli and purified by proprietary chromatographic technique. |
Recombinant HTLV-1 Mosaic Protein |
VAng-Lsx0310-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Mosaic Protein, recombinant protein from E. coli. |
Recombinant MeV Hemagglutinin Mosaic Protein |
VAng-Lsx0386-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant MeV HA protein containing the large hemagglutinin immunodominant regions 1-30, 115-150 and 379-410 amino acids was expressed in E. coli and purified by proprietary chromatographic technique. |
Recombinant MeV Fusion Mosaic Protein |
VAng-Lsx0387-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: MeV Fusion Mosaic protein, recombinant protein from E. coli. |
Recombinant EBV P18 Mosaic Protein |
VAng-Lsx0115-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: EBV P18 Mosaic protein, recombinant protein from E. coli. |
Anti-SARS-CoV-2 Antibody |
A2061-50 |
Biovision |
50 µg |
EUR 480 |
Recombinant Coronavirus Nucleoprotein (SARS-CoV) |
P1509-10 |
Biovision |
10µg |
EUR 551 |
Sars ORF Vector (Rat) (pORF) |
ORF075828 |
ABM |
1.0 ug DNA |
EUR 506 |
SARS ORF Vector (Human) (pORF) |
ORF009202 |
ABM |
1.0 ug DNA |
EUR 95 |
SARS ORF Vector (Human) (pORF) |
ORF009203 |
ABM |
1.0 ug DNA |
EUR 95 |
Sars ORF Vector (Mouse) (pORF) |
ORF056671 |
ABM |
1.0 ug DNA |
EUR 506 |
Sars ORF Vector (Mouse) (pORF) |
ORF056672 |
ABM |
1.0 ug DNA |
EUR 506 |
SARS Coronavirus IgG ELISA Kit |
DEIA1035 |
Creative Diagnostics |
96T |
EUR 2159 |
Description: For the qualitative determination of IgG class antibodies against SARS Coronavirus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by SARS Coronavirus. |
SARS Coronavirus IgM ELISA Kit |
DEIA1036 |
Creative Diagnostics |
96T |
EUR 2159 |
Description: For the qualitative determination of IgM class antibodies against SARS Coronavirus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by SARS Coronavirus. |
SARS-CoV spike protein Antibody |
abx023139-100ug |
Abbexa |
100 ug |
EUR 857 |
|
SARS-CoV spike protein Antibody |
abx023143-100ug |
Abbexa |
100 ug |
EUR 857 |
|
SARS Polyclonal Antibody, HRP Conjugated |
A53978 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: kits suitable for this type of research |
SARS Polyclonal Antibody, FITC Conjugated |
A53979 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: fast delivery possible |
SARS Polyclonal Antibody, Biotin Conjugated |
A53980 |
EpiGentek |
100 µg |
EUR 570.55 |
Description: reagents widely cited |
Recombinant SARS Associated Coronavirus Matrix |
7-07114 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Coronavirus Matrix |
7-07115 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Coronavirus Matrix |
7-07116 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant SARS Associated Coronavirus Envelope |
7-07117 |
CHI Scientific |
100µg |
Ask for price |
Recombinant SARS Associated Coronavirus Envelope |
7-07118 |
CHI Scientific |
500µg |
Ask for price |
Recombinant SARS Associated Coronavirus Envelope |
7-07119 |
CHI Scientific |
1000µg |
Ask for price |
SARS Associated Coronavirus Matrix Protein |
20-abx260150 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1372.00
|
|
|
SARS Associated Coronavirus Envelope Protein |
20-abx260151 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1372.00
|
|
|
Recombinant SARS S1 Protein [His] |
VAng-Lsx0061-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS S1 [His], recombinant protein from E. coli. |
Recombinant SARS S2 Protein [His] |
VAng-Lsx0062-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS S2 [His], recombinant protein from E. coli. |
Recombinant (E.Coli) Circumsporozoite (CSP) mosaic protein (107-129, 334-351 aa) (P.falciparum) mosaic protein |
CSPF16-R |
Alpha Diagnostics |
50 ug |
EUR 347 |
Recombinant P. Falciparum Circumsporozoite Mosaic protein |
DAG1344 |
Creative Diagnostics |
100 µg |
EUR 645 |
Recombinant HIV-1 gp120 nef Mosaic |
7-07657 |
CHI Scientific |
100µg |
Ask for price |
The regular states of the mannequin are analyzed and the sensitivity evaluation of the fundamental reproductive quantity is explored. Furthermore to parameterize the mannequin an actual knowledge of SARS-CoV-2 virus reported within the Sultanate of Oman from January 1st, 2021 to Could 23rd, 2021 are used. We then carry out the massive scale numerical findings to point out the validity of the analytical work.